Caris Life Sciences (CAI) Inventory Average (2025 - 2026)
Caris Life Sciences (CAI) recorded quarterly Inventory Average of $70.0 million in Q1 2026, up 23.9% quarter-over-quarter from $56.5 million in Q4 2025.
Caris Life Sciences (CAI) Inventory Average (2025 - 2026) Analysis & Trends
Caris Life Sciences' Inventory Average history runs 2 years deep, the most recent figure standing at $70.0 million for Q1 2026.
- In Q1 2026, Inventory Average changed N/A year-over-year to $70.0 million; the TTM figure through Mar 2026 stood at $70.0 million (changed N/A YoY), while the FY2025 annual figure was $51.6 million, changed N/A from the prior year.
- Inventory Average was $70.0 million for Q1 2026 at Caris Life Sciences, up from $56.5 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $70.0 million in Q1 2026 to a low of $45.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn | 69.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.96 Mn |
| Dec 31, 2025 | 56.46 Mn |
| Sep 30, 2025 | 44.96 Mn |